Additional information
Free Base: 439081-18-2
Off white Powder
850140-73-7
ACI-015500
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate(1:2)
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate
150.6-152.5°C
C24H25ClFN5O3. 2C4H4O
718.08
Ambient
2-8°C
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate
Metastatic
Pharmacopeial Reference Standards





![3-METHYL TOLVAPTAN (25 mg) (N-[4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-2-methylphenyl]-2-methylbenzamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)